Division of Thoracic and Cardiovascular Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Department of Thoracic Surgery, National Hospital Organization Nishi-Niigata Chuo Hospital, Niigata, Japan.
Interact Cardiovasc Thorac Surg. 2021 May 27;32(6):896-903. doi: 10.1093/icvts/ivab025.
The optimal surgical approach for metachronous second primary lung cancer (MSPLC), especially ipsilateral MSPLC, remains unclear. This study aimed to review postoperative complications and examine surgical outcomes based on the extent of resection after surgery for ipsilateral MSPLC.
Clinical data from 61 consecutive patients who underwent pulmonary resection for ipsilateral MSPLC according to the Martini-Melamed criteria between January 2005 and December 2017 in 3 institutes were retrospectively reviewed.
Postoperative complications were identified in 12 patients (19.7%). Regarding the combination of initial and second surgery, intraoperative bleeding was significantly greater in patients with anatomic-anatomic resection than in others (P < 0.001). Operation time was significantly longer in patients with anatomic-anatomic resection than in others (P < 0.001). However, postoperative complications showed no significant differences based on the combination of surgeries. Five-year overall survival rates in patients with anatomic resection and wedge resection after second surgery were 75.8% and 75.8%, respectively (P = 0.738), and 5-year recurrence-free survival rates were 54.2% and 67.6%, respectively (P = 0.368). Cox multivariate analysis identified ever-smoker status (P = 0.029), poor performance status (P = 0.011) and tumour size >20 mm (P = 0.001) as independent predictors of poor overall survival, while ever-smoker status (P = 0.040) and tumour size >20 mm (P = 0.007) were considered independent predictors of poor recurrence-free survival.
Regarding postoperative and long-term outcomes for patients with ipsilateral MSPLC, surgical intervention is safe and offers good long-term survival. Wedge resection is an acceptable provided tumours ≤2 cm and ground-glass opacity-predominant as a second surgery for early-stage ipsilateral MSPLC.
对于异时性第二原发性肺癌(MSPLC),特别是同侧 MSPLC,最佳手术方法仍不明确。本研究旨在根据 Martini-Melamed 标准对 3 家医院 2005 年 1 月至 2017 年 12 月间连续 61 例接受同侧 MSPLC 肺切除术的患者的术后并发症进行回顾分析,并检查手术结果。
回顾性分析了根据 Martini-Melamed 标准对 3 家医院 2005 年 1 月至 2017 年 12 月间连续 61 例接受同侧 MSPLC 肺切除术的患者的临床资料。
12 例患者(19.7%)发生术后并发症。关于初始和第二次手术的联合,解剖解剖切除的患者术中出血量明显大于其他患者(P<0.001)。解剖解剖切除的患者手术时间明显长于其他患者(P<0.001)。然而,术后并发症的组合没有显著差异。第二次手术后行解剖性切除和楔形切除术的患者 5 年总生存率分别为 75.8%和 75.8%(P=0.738),5 年无复发生存率分别为 54.2%和 67.6%(P=0.368)。Cox 多因素分析发现,既往吸烟史(P=0.029)、较差的一般状态(P=0.011)和肿瘤直径>20mm(P=0.001)是总生存不良的独立预测因素,而既往吸烟史(P=0.040)和肿瘤直径>20mm(P=0.007)是无复发生存不良的独立预测因素。
对于同侧 MSPLC 患者的术后和长期预后,手术干预是安全的,可获得良好的长期生存。楔形切除术是一种可接受的方法,适用于肿瘤直径≤2cm 且磨玻璃影为主的早期同侧 MSPLC 作为第二次手术。